Avantor Inc logo

AVTRAvantor Inc

NYSE · Healthcare · Medical Instruments & Supplies

$14.73

+$0.53 (+3.73%)

Avantor Inc (AVTR) is a medical instruments & supplies company listed on NYSE. It is led by Michael Stubblefield, based in Radnor Corporate Center, Radnor, PA, United States, 19087, with about 13,500 employees. Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, peristaltic pumps, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, compound management, cleanroom control, monitoring, maintenance, and sanitization services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.

Latest reported AVTR revenue for 2025-09-30 was $1.62B. Net income was -$711.8M. Revenue was down 3.5% from 2025-06-30 to 2025-09-30. AVTR currently screens at market cap $9.36B and trailing P/E 13.3.

Use this AVTR page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the AVTR quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the AVTR SEC filings page. Lician reads the product cache first so this HTML stays unique to Avantor Inc even when a live quote feed is slow.

About Avantor Inc

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, peristaltic pumps, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, compound management, cleanroom control, monitoring, maintenance, and sanitization services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.

AVTR Key Statistics

Market Cap

$9.36B

Volume

5.56M

Previous Close

$14.26

Day Range

$14.05$14.50

P/E Ratio

13.26

0

EPS

$1.04

Revenue

$6.78B

Net Income

$711.50M

Gross Profit

$0.00

Free Cash Flow

$0.00

Revenue Growth

-2.6%

Profit Margin

10.5%

Employees

13,500

AVTR Financials

Annual income statement in USD. Latest reported periods first.

AVTR annual income statement across FY2024, FY2023, FY2022, FY2021
LineFY2024FY2023FY2022FY2021
Revenue$6.78B$6.97B$7.51B$7.39B
Cost of Revenue$0.00$0.00$0.00$0.00
Gross Profit$0.00$0.00$0.00$0.00
Operating Income$0.00$0.00$0.00$0.00
Net Income$711.50M$321.10M$686.50M$572.60M
EPS (Diluted)$1.04$0.47$1.01$0.85

Total Assets

$12.11B

Total Debt

$0.00

Shareholders' Equity

$0.00

Cash & Equivalents

$261.90M

Operating Cash Flow

$840.80M

Free Cash Flow

$0.00

Avantor Inc Company Information

President, CEO & Director
Michael Stubblefield
Headquarters
Radnor Corporate Center, Radnor, PA, United States, 19087
Phone
610 386 1700
IPO / Founded
2019-05-17
Industry
Medical Instruments & Supplies
Data Updated:

Upcoming Events for AVTR